期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

他汀类药物与甲状腺疾病 被引量：6

Statins and thyroid diseases
原文传递
导出
摘要 甲状腺疾病如甲状腺癌、甲状腺结节在全球范围内的发病率和患病率逐年升高.他汀类药物抑制胆固醇合成的同时,抑制甲羟戊酸及其下游产物,阻断了与肿瘤增殖、新生血管形成及肿瘤转移相关信号通路,进而发挥抑制肿瘤细胞生长的作用.此外,他汀类药物还可减少甲状腺结节的体积及患病率,通过免疫调节作用改善桥本甲状腺炎患者的甲状腺功能,并能对甲状腺相关眼病的进展起到缓解作用. The incidence and prevalence of thyroid diseases such as thyroid cancer and thyroid nodule are increasing worldwide.By blocking mevalonate and related downstream pathways,statins inhibit proliferation,angiogenesis and metastasis of cancer cells as well as cholesterol production,finally lead to growth inhibition of cancer cells.Furthermore,statins reduce the volume of thyroid nodule and its prevalence,and improve thyroid function in patients with Hashimoto＇s thyroiditis through immunomodulation.Meanwhile,statins can delay the progression of thyroid associated ophthalmopathy.
作者 陈鹏 徐书杭 陈国芳 刘超
机构地区 南京中医药大学附属中西医结合医院内分泌代谢病院区
出处 《国际内分泌代谢杂志》 北大核心 2013年第5期308-310,313,共4页 International Journal of Endocrinology and Metabolism
基金 国家自然科学基金资助项目（81200577）
关键词 他汀类药物 甲状腺癌 甲状腺结节 桥本甲状腺炎 甲状腺相关眼病 Statins Thyroid cancer Thyroid nodule Hashimoto＇s thyroiditis Thyroid associated ophthalmopathy
分类号 R581 [医药卫生—内分泌]
  • 相关文献

参考文献23

  • 1Guo H,Sun M,He W,et al.The prevalence of thyroid nodules and its relationship with metabolic parameters in a Chinese community-based population aged over 40 years.Endocrine,2013,[Epub ahead of print].
  • 2刘玉琴,张书全,陈万青,陈莉莉,张思维,张小栋,郑荣寿.中国2003--2007年甲状腺癌发病死亡现状及流行趋势分析[J].中华流行病学杂志,2012,33(10):1044-1048. 被引量：165
  • 3Siegel R,Naishadham D,Jemal A.Cancer statistics,2013.CA Cancer J Clin,2013,63:11-30.
  • 4Bifulco M.Therapeutic potential of statins in thyroid proliferative disease.Nat Clin Pract Endocrinol Metab,2008,4:242-243.
  • 5Zeybek ND,Gulcelik NE,Kaymaz FF,et al.Rosuvastatin induces apoptosis in cultured human papillary thyroid cancer cells.J Endocrinol,2011,210:105-115.
  • 6Zhong WB,Hsu SP,Ho PY,et al.Lovastatin inhibits proliferation of anaplastic thyroid cancer cells through up-regulation of p27 by interfering with the Rho/ROCK-mediated pathway.Biochem Pharmacol,2011,82:1663-1672.
  • 7Shui HA,Hsia CW,Chen HM,et al.Proteomics and bioinformatics analysis of lovastatin-induced differentiation in ARO cells.J Proteomics,2012,75:1170-1180.
  • 8Chung YS,Cho S,Ryou HJ,et al.Is there a treatment advantage when paclitaxel and lovastatin are combined to dose anaplastic thyroid carcinoma cell lines.Thyroid,2011,21:735-744.
  • 9Wang CY,Shui HA,Chang TC.In vivo evidence of duality effects for lovastatin in a nude mouse cancer model.Int J Cancer,2010,126:578-582.
  • 10Fang Z,Tang Y,Fang J,et al.Simvastatin inhibits renal cancer cell growth and metastasis via AKT/mTOR,ERK and JAK2/STAT3 pathway.PLoS One,2013,8:e62823.

二级参考文献27

  • 1陈勇,陈建国,沈洪兵,徐耀初.启东1972～2001年恶性肿瘤发病率时间趋势分析[J].疾病控制杂志,2006,10(2):105-108. 被引量：16
  • 2Song C,Guo Z,Ma Q,et al.Simvastatin induces osteoblastic differentiation and inhibits adipocytic differentiation in mouse bone marrow stromal cells[J].Biochem Biophys Res Commun,2003,308(3):458-462.
  • 3Nicholson A C,Hajjar D P,Zhou X,et al.Anti-adipogenic action of pitavastatin occurs through the coordinate regulation of PPARgamma and Pref-1 expression[J].Br J Pharmacol,2007,151(6):807-815.
  • 4Tamori Y,Masugi J,Nishino N,et al.Role of peroxisome proliferator-activated receptor-γ in maintenance of the characteristics of mature 3T3-L1 adipocytes[J].Diabetes,2002,51(7):2045-2055.
  • 5Mimura L Y,Villares S M,Monteiro M L,et al.Peroxisome proliferator-activated receptor-gamma gene expression in orbital adipose/connective tissues is increased during the active stage of Grave's ophthalmopathy[J].Thyroid,2003,13(9):845-850.
  • 6Vondrichova T,de Capretz A,Parikh H,et al.COX-2 and SCD,markers of inflammation and adipogenesis,are related to disease activity in Grave's ophthalmopathy[J].Thyroid,2007,17(6):511-517.
  • 7Valyasevi R W,Harteneck D A,Dutton C M.Stimulation of adipogenesis,peroxisome proliferator-activated receptor-gamma (PPAR gamma),and thyrotropin receptor by PPAR gamma agonist in human orbital preadipocyte fibroblasts[J].J Clin Endocrinol Metab,2002,87(5):2352-2358.
  • 8Feldon S E,O'loughlin C W,Ray D M,et al.Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes[J].Am J Pathol,2006,169(4):1183-1193.
  • 9Feldon S E,Park D J,O'Loughlin C W,et al.Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Grave's ophthalmopathy[J].Invest Ophthalmol Vis Sci,2005,46(11):3913-3921.
  • 10Cawood T J,Moriarty P,O'Farrelly C,et al.The effects of tumour necrosis factor-alpha and interleukin1 on an in vitro model of thyroid-associated ophthalmopathy; contrasting effects on adipogenesis[J].Eur J Endocrinol,2006,155(3):395-403.

共引文献164

同被引文献96

  • 1汪慧敏.治未病与隔药饼灸治疗复发性子宫内膜异位症[A].见:世界卫生组织传统医学大会针灸与人类健康卫星研讨会论文摘要汇编[C].北京:中国国家中医药管理局,2008:276.
  • 2Mihailovoc JM, Stefanovic LJ, Malesevic MD, et al. Metastic differentiated thyroid carcinoma: clinical management and outcome of disease in patients with initial and late distant metastases [ J ]. Nucl Med Commun,2009 ,30 :558-564.
  • 3Vaughan C J, Murphy MB, Buckley BM. Statins do more than just lower cholesterol [ J ]. Lancet, 1996,348 : 1079-1082.
  • 4Friis S, Olsen JH. Statin use and cancer risk: an epidemiologic review[ J]. Cancer Invest,2006,24:413-424.
  • 5Zeybek ND, Gulcelik NE, Kaymaz FF, et al. Rosuvastatin induces apoptosis in cultured human papillary thyroid cancer ceils [ J ]. J Endocrino1,2011,210 : 105-115.
  • 6Zhong WB, Hsu SP, Ho PY, et al. Lovastatin inhibits proliferation of anaplastic thyroid cancer cells through up-regulation of p27 by interfering with the Rho/Rock-mediated pathway [ J ] . Biochem Pharmacol,2011,82 : 1663-1672.
  • 7Wang CY,Shui HA, Chang TC. In vivo evidence of duality effects for lovastatin in a nude mouse cancer model [ J ]. Int J Cancer, 2010,126:578-582.
  • 8Libertini S, Iacuzzo I, Ferraro A, et al. Lovastatin enhances the replication of the oncolytic adenovirus d11520 and its antineoplastic activity against anaplastic thyroid carcinoma cells [ J ]. Endocrinology ,2007,148:5186-5194.
  • 9Zhong WB, Liang YC, Wang CY, et al. Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling [ J ]. Endocr Relat Cancer,2005,12:615-629.
  • 10Zhong WB, Wang CY, Chang TC, et al. Lovastatin induces apoptosis of anaplastic thyroid cancer cells via inhibition of protein geranylgeranylation and de novo protein synthesis [ J ]. Endocrinology,2003,144:3852-3859.

引证文献6

二级引证文献46

国际内分泌代谢杂志
2013年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部